Company Filing History:
Years Active: 1998-1999
Title: The Innovative Contributions of Sarah Jane Eccles
Introduction
Sarah Jane Eccles is a prominent inventor based in London, GB. She has made significant contributions to the field of gene therapy and molecular biology. With a total of 2 patents, her work focuses on advancing the understanding and application of gene expression in mammalian cells.
Latest Patents
One of her latest patents is titled "Vector for integration site independent gene expression in mammalian." This invention involves a vector designed for the integration of a gene into the genetic material of a mammalian host cell, allowing for the expression of the gene by the host cell. The vector includes a promoter and an immunoglobulin dominant control region derived from the mouse .lambda. immunoglobulin gene locus. This innovation is capable of eliciting host cell-type restricted, integration site independent, copy number dependent expression of the gene. The patent also describes methods for gene therapy, including the transformation of stem cells and the production of polypeptides through cultured transformed mammalian cells.
Career Highlights
Sarah Jane Eccles is affiliated with the Medical Research Council, where she conducts her research and development work. Her contributions to the field have been recognized for their potential impact on gene therapy and genetic research.
Collaborations
She collaborates with notable colleagues, including Franklin Gerardus Grosveld, to further enhance her research efforts and innovations.
Conclusion
Sarah Jane Eccles is a trailblazer in the field of gene therapy, with her innovative patents paving the way for advancements in genetic research and applications. Her work continues to inspire future developments in the field.